Clinical Research Management Briefing – January 16, 2018
The U.S. Office of Management and Budget (OMB) seeks to delay enforcement of the revised Common Rule, originally slated to take effect in 2018, providing additional time for the federal government to issue implementation guidance.
Outsourcing-Pharma, January 9
In the wake of failed clinical trials, Pfizer will end its neuroscience discovery and early development work, but intends to launch a venture fund to support external industry initiatives.
NPR, January 8
The National Institutes of Health (NIH) is seeing progress in the volume of clinical trials registered and shared via the National Library of Medicine’s (NLM) online database, despite lax enforcement.
Regulatory Affairs Professionals Society, January 9
NLM rolled out a series of new functionality to it online clinical trials database, including an expanded search feature, glossary tool and ability to track the quality control review process.
The Association of Clinical Research Professionals, January 2
Amgen, Pfizer and Sanofi are collaborating to bring blockchain technology to clinical research, an innovation that could mitigate the industry’s data portability, transparency and patient engagement challenges.
CoinDesk, January 9
Patient Services, Inc. filed a lawsuit against the federal government for allegedly impeding communication between the charity and its donors.
The Washington Post, January 8
GlaxoSmithKline has been on a multiyear journey to transform the data foundation of its R&D arm, partnering with vendors to ensure internal and third-party insights are accessible and actionable.
Forbes, January 8Contact Us